[HTML][HTML] Design of bio-responsive hyaluronic acid–doxorubicin conjugates for the local treatment of glioblastoma

A Malfanti, G Catania, Q Degros, M Wang, M Bausart… - Pharmaceutics, 2022 - mdpi.com
Glioblastoma is an unmet clinical need. Local treatment strategies offer advantages, such as
the possibility to bypass the blood–brain barrier, achieving high drug concentrations at the …

Design of Bio-Responsive Hyaluronic Acid-Doxorubicin Conjugates for the Local Treatment of Glioblastoma.

A Malfanti, G Catania, Q Degros, M Wang… - …, 2022 - europepmc.org
Glioblastoma is an unmet clinical need. Local treatment strategies offer advantages, such as
the possibility to bypass the blood–brain barrier, achieving high drug concentrations at the …

Design of Bio-Responsive Hyaluronic Acid–Doxorubicin Conjugates for the Local Treatment of Glioblastoma

A Malfanti, G Catania, Q Degros, M Wang… - …, 2022 - search.proquest.com
Glioblastoma is an unmet clinical need. Local treatment strategies offer advantages, such as
the possibility to bypass the blood–brain barrier, achieving high drug concentrations at the …

Design of Bio-Responsive Hyaluronic Acid–Doxorubicin Conjugates for the Local Treatment of Glioblastoma

A Malfanti, G Catania, Q Degros, M Wang… - …, 2022 - research.unipd.it
Glioblastoma is an unmet clinical need. Local treatment strategies offer advantages, such as
the possibility to bypass the blood-brain barrier, achieving high drug concentrations at the …

Design of Bio-Responsive Hyaluronic Acid-Doxorubicin Conjugates for the Local Treatment of Glioblastoma

A Malfanti, G Catania, Q Degros, M Wang… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Glioblastoma is an unmet clinical need. Local treatment strategies offer advantages, such as
the possibility to bypass the blood-brain barrier, achieving high drug concentrations at the …

[PDF][PDF] Design of Bio-Responsive Hyaluronic Acid–Doxorubicin Conjugates for the Local Treatment of Glioblastoma. Pharmaceutics 2022, 14, 124

A Malfanti, G Catania, Q Degros, M Wang, M Bausart… - 2022 - dial.uclouvain.be
Glioblastoma is an unmet clinical need. Local treatment strategies offer advantages, such as
the possibility to bypass the blood–brain barrier, achieving high drug concentrations at the …

[HTML][HTML] Design of Bio-Responsive Hyaluronic Acid–Doxorubicin Conjugates for the Local Treatment of Glioblastoma

A Malfanti, G Catania, Q Degros, M Wang… - …, 2022 - ncbi.nlm.nih.gov
Glioblastoma is an unmet clinical need. Local treatment strategies offer advantages, such as
the possibility to bypass the blood–brain barrier, achieving high drug concentrations at the …

[PDF][PDF] Design of Bio-Responsive Hyaluronic Acid–Doxorubicin Conjugates for the Local Treatment of Glioblastoma. Pharmaceutics 2022, 14, 124

A Malfanti, G Catania, Q Degros, M Wang, M Bausart… - 2022 - pdfs.semanticscholar.org
Glioblastoma is an unmet clinical need. Local treatment strategies offer advantages, such as
the possibility to bypass the blood–brain barrier, achieving high drug concentrations at the …

Design of Bio-Responsive Hyaluronic Acid–Doxorubicin Conjugates for the Local Treatment of Glioblastoma.

A Malfanti, G Catania, Q Degros, M Wang… - …, 2022 - search.ebscohost.com
Glioblastoma is an unmet clinical need. Local treatment strategies offer advantages, such as
the possibility to bypass the blood–brain barrier, achieving high drug concentrations at the …

Design of Bio-Responsive Hyaluronic Acid-Doxorubicin Conjugates for the Local Treatment of Glioblastoma.

A Malfanti, G Catania, Q Degros, M Wang… - …, 2022 - dial.uclouvain.be
Glioblastoma is an unmet clinical need. Local treatment strategies offer advantages, such as
the possibility to bypass the blood-brain barrier, achieving high drug concentrations at the …